Clinical Trials Browser

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Cardiovascular Diseases, Colonic Neoplasms, Diabetes Mellitus, Esophageal Neoplasms, Head and Neck Neoplasms, Hypercholesterolemia, Hypertension, Liver Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Endometrial Neoplasms

NCT04751929 2026-02-20

Abemaciclib With or Without Atezolizumab for mCRPC

Phase 2 Active not recruiting

19 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT05668351 2026-02-19

SUPR-SABR

Phase NA Active not recruiting

42 enrolled

Genitourinary

Prostatic Neoplasms

NCT03263650 2026-02-17

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Phase 2 Active not recruiting

96 enrolled

Genitourinary

Prostate Cancer, Hereditary, 7, Prostatic Neoplasms

NCT05160597 2026-02-12

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

Phase EARLY_PHASE1 Active not recruiting

30 enrolled

Genitourinary

Prostatic Neoplasms

NCT05320406 2026-02-12

REVELUTION

Phase 2 Active not recruiting

94 enrolled 13 charts

Genitourinary

Prostatic Neoplasms

NCT06627530 2026-02-11

COAction

Phase 4 Active not recruiting

144 enrolled

Genitourinary

Prostatic Neoplasms

Clinical Trials

PREPARE SBRT

Evaluation of an Active Surveillance Protocol for Prostate Cancer in the Brazilian Population

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer

RADVAN

A Study to Evaluate Hypofractionated Proton Therapy or IMRT for Recurrent, Oligometastatic Prostate Cancer

GARUDA

Exercise for Tumor Suppressive Impact in Black Men With Prostate Cancer on Active Surveillance: The REMOVE Trial

Golimumab and Apalutamide for the Treatment of Castration-Resistant Prostate Cancer, TRAMP Study

Leveraging EA8191 to Assess AI-Augmented EHR Abstraction

SMILE

A mLifestyle Intervention for Men on Androgen Deprivation Therapy for PCa

Brachytherapy for Prostatic Carcinoma Patients

Molecular Studies and Clinical Correlations in Human Prostatic Disease

COMPPARE

MRI Guided SBRT for Localized Prostate Cancer

The Effect of Deep Versus Moderate Muscle Relaxants in Men During and After Robotic Surgery for Prostate Cancer

Comeback From Long coursE Androgen Deprivation Therapy (ADT) With RElugolix and Darolutamide (CLEARED)

Abiraterone Acetate, Prednisone, and Apalutamide With or Without Ipilimumab or Cabazitaxel and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer

Focal Radiation With Pulsed Systemic Therapy of Abiraterone, Androgen Deprivation Therapy (ADT), Lynparza Towards Castration Sensitive Oligometastatic Prostate Cancer (FAALCON)

COMBINE-P

Magnetic Resonance Whole Body Diffusion-Weighted Imaging in Finding Bone or Lymph Node Metastasis in Participants With High-Risk Prostate Cancer

PCGA

MRL-Boost PC

NeoAdjuvant Theranostic Lutetium Study: The Nautilus Trial

Study of Drug 1 (Enzalutamide) Plus Drug 2 (Relacorilant) for Patients With Prostate Cancer

LIAM Mc

PRIMARY2

Sense of Coherence and Quality of Life in Prostate Cancer Patients Treated With Radical Radiotherapy

VANDAAM

Enzalutamide With or Without Radium Ra 223 Dichloride in Patients With Metastatic, Castration-Resistant Prostate Cancer

A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer

Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer

Enzalutamide and Cabazitaxel in Treating Patients With Metastatic, Castration-Resistant Prostate Cancer

Cognitive Effects of Androgen Receptor Directed Therapies for Advanced Prostate Cancer

BLaStM

Stereotactic Ablative Radiotherapy (SABR) of Pelvis and Prostate Targets For High Risk Prostate Cancer

CART-PSMA-TGFβRDN Cells for Castrate-Resistant Prostate Cancer

Evaluation of the Impact of Empty Versus Full Bladder in Patients With Prostate Cancer, RELIEF Trial

Multimodal Therapy for the Treatment of Fatigue in Patients With Prostate Cancer Receiving Radiotherapy With Androgen Deprivation Therapy

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

RCMIGI

Evaluating in Vivo PARP-1 Expression With 18F-FluorThanatrace Positron Emission Tomography (PET/CT) in Prostate Cancer

ONE TEAM

Abemaciclib With or Without Atezolizumab for mCRPC

SUPR-SABR

Study of Olaparib Maintenance Following Cabazitaxel-Carbo in Men With AVPC

Image-Guided (68Ga-PSMA-11 PET/CT) Prostate Biopsy for the Diagnosis of Prostate Cancer in Men With Prior Negative/Inconclusive Biopsy

REVELUTION

COAction